Can cashew allergy be outgrown? new study tests oral immunotherapy

NCT ID NCT07158619

Not yet recruiting Disease control Sponsor: Medical University of Warsaw Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study follows 39 children with cashew allergy who previously received oral immunotherapy (OIT) with cashew protein. After 8 more months of OIT, they will stop treatment for 4 weeks and then take a food challenge to see if they can safely eat cashews without ongoing therapy. The goal is to find out if sustained unresponsiveness—lasting tolerance—can be achieved.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: cashew nut protein (oral immunotherapy)
What this could lead to: If successful, this could show that a period of oral immunotherapy helps children with cashew allergy eat cashews safely even after stopping treatment.
What could go wrong: This is a small, early follow-up study with only 39 participants. It is not yet recruiting, and results may not apply to all children. Allergic reactions during treatment are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FOOD ALLERGY IN CHILDREN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

food allergy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FOOD ALLERGY IN CHILDREN

Contacts and locations

Locations

Medical University of Warsaw

Warsaw, Masovian Voivodeship, 02-091, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.